REGISTERED COMPANY NUMBER: 06996068 (England and Wales)
REGISTERED CHARITY NUMBER: 1132984
REPORT OF THE TRUSTEES AND
UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST AUGUST 2022
FOR
THE INTERNATIONAL CML FOUNDATION
Gibbons Mannington & Phipps LLP
Chartered Accountants
20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE
THE INTERNATIONAL CML FOUNDATION
CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST AUGUST 2022
----- Start of picture text -----
Page
Report of the Trustees 1 to 4
Independent Examiner's Report 5
Statement of Financial Activities 6
Balance Sheet 7
Notes to the Financial Statements 8 to 15
----- End of picture text -----
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST AUGUST 2022
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006, present
theirreportwiththefinancialstatementsofthecharityfortheyearended31stAugust2022. The
trusteeshaveadoptedtheprovisionsofAccountingandReportingbyCharities:Statement of
RecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and aims
TheobjectoftheFoundationistheadvancementofhealthbytheimprovementofthetreatmentin all
partsoftheworldofchronicmyeloidleukaemiaandrelateddiseases(together"CML")andfor the
purpose of carrying out those general objects, the primary objects of the Foundation are in particular:-
(i) to improve clinical practice and disease monitoring in the treatment of CML
(ii) to support, encourage and promote research into the causes, prevention, study and treatment of CML
(iii)topromoteandsupporttheeducationofanddisseminateknowledgeamongstclinicians, scientists,
health professionals and patients in matters concerning CML
(iv)topromote,fosterandco-ordinatecollaborationthatisparticularly(butnotexclusively) international
andisnotonlyintheareasandactivitiesofclinicalpracticediseasemonitoringandresearchinto CML
butalsoinanyareaoractivitywhichisormaybeconducivetotheaccelerationofthecontrol and/or
cure of CML
(v)topromote,setup,establishandsupportandshareandexchangeknowledgewith other
organisations whose objects are similar to these general or primary objects
(vi)toassistorpromoteanyothercharitablepurposeswhicharerelatedtothesegeneraland primary
objects.
Significant activities
In furtherance of the objects, the Foundation has the following powers:-
(i) to promote or carry out research
(ii) to provide advice
(iii) to give and exchange information and advice and promote learning, study and research
(iv)tocommission,publish,distributeandcontributetopapers,books,periodicals,reports, leaflets,
posters and other publications of any description
(v) to hold, attend and sponsor conferences, meetings, lectures, exhibitions and discussions
(vi)toraisefundsandtoapplyforandsolicitgrantsfrompharmaceuticalcompaniesanywherein the
world.
Public benefit
TheTrusteeshaveconsideredtheirdutytohavedueregardtopublicbenefitguidancepublishedby the
Commissionandintheiropinion,theforegoingreportontheachievementsand performance
demonstrates that they have complied therewith.
Page 1
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST AUGUST 2022
ACHIEVEMENT AND PERFORMANCE
Charitable activities
TheiCMLfcontinuedtoleadtheCMLcommunitywiththeCOVID-19&CMLcasecollection,analysis and
treatmentguidance.Thereare3iCMLfinternationalresearchprojectsunderway.Theonline webinars
continueforCOVIDguidanceandotherkeyareasofCMLmanagement.Withthelaunchofthe iCMLf
KnowledgeCentre,aneweducationalprogramspecificallyfornon-academiccentres,theiCMLf continues
to be at the forefront of CML education and enhancing patient management around the world.
Global Research Programs
Covid-19(CANDID)study-Thisremainedasignificantfocusfortheyear.Thecompleted dataset
included1,050casesfrom900physiciansin58countries.thedataiswidelyrespectedwith4 further
presentations at international conferences.
Cure Consortium
iCMLfTreatmentFreeRemissionAlliance-GlobalTFRregistrybeganinFebruary2022.24sitesfrom 16
countries and 2.900 potential datasets. Site initiation remains ongoing.
iCMLfGenomicAlliance-TheiCMLfgenomicsproject'ClonalHierarchyinCML'datauploadis underway.
12 sites from 10 countries participating.
Online CML Education
iCMLfClinicalConversations-9discussionswith16expertsfrom10countrieswithover300 live
participants and 3,000 online participants.
iCMLf Knowledge Centre
TheKnowledgeCentreisaninteractive,onlineresourceprovidingeducationalcontentforholistic CML
patient management. 33 speaker from 16 countries with 1,600 users.
FINANCIAL REVIEW
Financial position
The financial position of the International CML Foundation remains solid.
Principal funding sources
TheiCMLfworkscloselywithindustryandcommunitypartnerstosecureunrestrictedgrants and
sponsorship for our programs and activities. The iCMLf requests donations through the iCMLf website.
Reserves policy
Thereservesattheyearendwere£328,540(2021-£305,347).ItisthepolicyoftheTrustees to
maintainsufficientreservestoensurethedaytodayrunningoftheFoundation.Thelevelofreserves and
currentfinancialcommitmentsarereviewedregularlyatTrustees'meetings.TheFoundationplansto hold
aminimumof£150,000asreservefunding.Thisistheamountforthefoundationtooperate without
further income/outgoings for one year.
FUTURE PLANS
WhilemaintainingtheexpertbestpracticeandeducationinitiativesoftheFoundation,weaimto harness
globalnetworkoftheiCMLftoenhanceresearchintopotentialcuresforCML.TheiCMLf Genomics
AlliancewillaccessthewealthofgenomicinformationthatisgeneratedinlocalCMLresearchprojects by
facilitatingdataassimilationandsamplesexchangesthroughaninternationaldatacollection platform.
Combiningmanydatasetsandfacilitatingglobalcollaborativestudieswillenableustodevelopa baseline
predictor of adverse outcomes.
TheiCMLfTFRAlliancelookstodefinebiomarkersfortreatmentdiscontinuationandafunctionalcure of
CML.
TheCMLandCOVID-19retrospectivecaseanalysiswillprovidedataforphysicianstobase treatment
decisions on as the pandemic continues.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrust,andconstitutesalimited company,
limited by guarantee, as defined by the Companies Act 2006.
Page 2
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST AUGUST 2022
STRUCTURE, GOVERNANCE AND MANAGEMENT
Recruitment and appointment of new trustees
ThepowerofappointingneworadditionalTrusteesisvestedintheexistingTrustees.Prior to
appointment,newTrusteeswouldbeintroducedtotheworkingsoftheFoundationandadvisedof their
responsibilities.
Organisational structure
The chief executive reports to the ten iCMLf Directors, specifically the iCMLf Chairman.
Theoperationalteam;CommunicationsDirector,CommunicationsManager,DigitalMediaOfficer, and
ERSAP Program Coordinator, report to the chief executive.
Strategicdirection,financialreviewandbudgetapprovalaresetatanannualiCMLfdirectorsmeeting in
September/October each year. Further directors planning and discussion meetings are held quarterly.
Strategicplanningisassistedwithanannualadvisorsmeeting.Thisincludesthethirteen physicians,
scientific and patient advisors and members from the 36 countries with iCMLf National Representatives.
Theoperationalteammeetsevery6-8weeks.Thecommunicationsdirector/communications manager
meetbiweeklywiththechiefexecutiverespectivelyandtheprogramcoordinatorandchief executive
meet weekly for business planning. The chief executive and iCMLf Chairman meet monthly.
Decisionsareescalatedfromtheoperationalteamtothechiefexecutive,iCMLfChairmanand iCMLf
Board of Directors according to scale and impact.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number
06996068 (England and Wales)
Registered Charity number
1132984
Registered office
20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE
Trustees
Professor T P Hughes
Professor M Baccarani Professor (resigned 20/12/2021)
Professor J Cortes Professor
Professor B Druker Professor
Professor A Hochhaus Professor
Professor J Radich Professor
Professor C Schiffer Professor
Professor J F Apperley DM FRCP/Path Professor
Professor M Mauro Professor
Professor G Saglio Professor
Company Secretary
Ms N C Evans
Independent Examiner
R Appleyard FCA
Gibbons Mannington & Phipps LLP
Chartered Accountants
20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE
Page 3
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST AUGUST 2022
REFERENCE AND ADMINISTRATIVE DETAILS
Bankers
HSBC Bank, 152 Portobello Road, London, W11 2EA
ThisreporthasbeenpreparedinaccordancewiththespecialprovisionsofPart15oftheCompanies Act
2006 relating to small companies.
Approved by order of the board of trustees on 11th May 2023 and signed on its behalf by:
Professor T P Hughes - Trustee
Page 4
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
Independent examiner's report to the trustees of The International CML Foundation ('the Company')
IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended
31st August 2022.
Responsibilities and basis of report
Asthecharity'strusteesoftheCompany(andalsoitsdirectorsforthepurposesofcompanylaw)you are
responsibleforthepreparationoftheaccountsinaccordancewiththerequirementsoftheCompanies Act
2006 ('the 2006 Act').
HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16 of
the2006Actandareeligibleforindependentexamination,Ireportinrespectofmyexaminationof your
charity'saccountsascarriedoutunderSection145oftheCharitiesAct2011('the2011Act').In carrying
outmyexaminationIhavefollowedtheDirectionsgivenbytheCharityCommissionunder Section
145(5) (b) of the 2011 Act.
Independent examiner's statement - matters of concern identified
I have completed my examination.
IdrawattentiontoNote10oftheaccounts,regardingthebalanceoffundsheldbyPaypal. Whilst
nothinghascometomyattentiontoindicatethatthebalanceshownintheaccountsisincorrect,it has
notbeenpossibletoverifythebalanceoffundsheldinthePaypalaccountaspartofmyexamination due
to the fact that the charity is currently unable to access the account.
Iconfirmthatnoothermattershavecometomyattentioninconnectionwiththeexaminationgiving me
reasonable cause to believe that in any material respect:
1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; and
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
Iconfirmthattherearenoothermatterstowhichyourattentionshouldbedrawntoenablea proper
understanding of the accounts to be reached.
R Appleyard FCA
Gibbons Mannington & Phipps LLP
Chartered Accountants
20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE
16th May 2023
Page 5
THE INTERNATIONAL CML FOUNDATION
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST AUGUST 2022
Unrestricted
funds
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
119,414
Other trading activities
2
279
Other income
3
23,495
Total
143,188
EXPENDITURE ON
Charitable activities
Diagnosis & testing
-
Scientific meetings
5,926
ICMLF Forum
17
Communications
31,816
Fundraising
12,448
Cure Consortium
14,102
Candid
-
Knowledge Centre
(20,073)
Conversations
23,403
Other
20,242
Total
87,881
NET INCOME/(EXPENDITURE)
55,307
RECONCILIATION OF FUNDS
Total funds brought forward
156,702
TOTAL FUNDS CARRIED FORWARD
212,009 |
Restricted
funds
£
66,043
-
-
66,043
11,784
-
-
372
-
-
23,304
61,138
1,559
-
98,157
(32,114)
148,645
116,531 |
2022
Total
funds
£
185,457
279
23,495
209,231
11,784
5,926
17
32,188
12,448
14,102
23,304
41,065
24,962
20,242
186,038
23,193
305,347
328,540 |
2021
Total
funds
£
75,107
-
(5,904)
69,203
-
696
3,402
29,031
8,913
5,147
35,113
21,529
28,938
13,891
146,660
(77,457)
382,804
305,347 |
|
|
|
|
The notes form part of these financial statements
Page 6
THE INTERNATIONAL CML FOUNDATION (REGISTERED NUMBER: 06996068)
BALANCE SHEET
31ST AUGUST 2022
Unrestricted
funds
Notes
£
CURRENT ASSETS
Debtors
10
102,793
Cash at bank and in hand
113,584
216,377
CREDITORS
Amounts falling due within one year
11
(4,368)
NET CURRENT ASSETS
212,009
TOTAL ASSETS LESS CURRENT
LIABILITIES
212,009
NET ASSETS
212,009
FUNDS
12
Unrestricted funds
Restricted funds
TOTAL FUNDS |
Restricted
funds
£
-
116,531
116,531
-
116,531
116,531
116,531 |
2022
Total
funds
£
102,793
230,115
332,908
(4,368)
328,540
328,540
328,540
212,009
116,531
328,540 |
2021
Total
funds
£
86,793
222,826
309,619
(4,272)
305,347
305,347
305,347
156,702
148,645
305,347 |
|
|
|
|
ThecharitablecompanyisentitledtoexemptionfromauditunderSection477oftheCompaniesAct 2006
for the year ended 31st August 2022.
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsforthe year
ended 31st August 2022 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicableto charitable
companies subject to the small companies regime.
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
11th May 2023 and were signed on its behalf by:
T P Hughes - Trustee
The notes form part of these financial statements
Page 7
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST AUGUST 2022
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
Thefinancialstatementsofthecharitablecompany,whichisapublicbenefitentityunderFRS 102,
havebeenpreparedinaccordancewiththeCharitiesSORP(FRS102)'Accountingand Reporting
byCharities:StatementofRecommendedPracticeapplicabletocharitiespreparingtheir accounts
inaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublicof Ireland
(FRS102)(effective1January2019)',FinancialReportingStandard102'TheFinancial Reporting
StandardapplicableintheUKandRepublicofIreland'andtheCompaniesAct2006.The financial
statements have been prepared under the historical cost convention.
Income
Items of income are recognised and included in the accounts when all of the following criteria
are met:
-
The charity or its subsidiary have entitlement to the funds;
-
any performance conditions attached to the item(s) of income have been met or are fully within the control of the charity or its subsidiary;
-
there is sufficient certainty that receipt of the income is considered probable; and
-
the amount can be measured reliably.
Expenditure
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthecharitytothatexpenditure,itisprobablethatatransferofeconomicbenefits will
berequiredinsettlementandtheamountoftheobligationcanbemeasuredreliably. Expenditure
isaccountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregate all
costrelatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadings they
have been allocated to activities on a basis consistent with the use of resources.
Debtors
Debtorsarerecognisedatthesettlementamountdueafteranytradediscount offered.
Prepayments are valued at the amount prepaid after taking account of any trade discounts due.
Creditors and provisions
Creditorsandprovisionsarerecognisedwherethecharityhasapresentobligationresultingfrom a
pasteventthatwillprobablyresultinthetransferoffundstoathirdpartyandtheamountdue to
settletheobligationcanbemeasuredorestimatedreliably.Creditorsandprovisionsare normally
recognised at their settlement amount after allowing for any trade discounts due.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestrictedfundscanbeusedinaccordancewiththecharitableobjectivesatthediscretionof the
trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsof the
charity.Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedfor particular
restricted purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
Foreign currencies
Assetsandliabilitiesinforeigncurrenciesaretranslatedintosterlingattheratesof exchange
rulingatthebalancesheetdate.Transactionsinforeigncurrenciesaretranslatedintosterling at
therateofexchangerulingatthedateoftransaction.Exchangedifferencesaretakeninto account
in arriving at the operating result and are shown as other income.
continued...
Page 8
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2022
2. OTHER TRADING ACTIVITIES
The iCMLf request donations through the iCMLf website.
3.
OTHER INCOME
Otherincomeconsistsoftheprofitonforeigncurrencyexchangeinaccordancewiththe accounting
policy on foreign exchange transactions.
4. SUPPORT COSTS
Management
fees
Finance
Other
£
£
£
Other resources
expended
17,586
268
567
Diagnosis & testing
11,784
-
-
Scientific meetings
1,785
-
-
Communications
27,990
-
-
Fundraising
5,034
17
1,966
Cure Consortium
10,926
-
-
Candid
22,403
-
-
Knowledge Centre
36,736
-
-
Conversations
23,501
-
-
157,745
285
2,533
Support costs, included in the above, are as follows:
Management fees
Other
resources
expended
£
Management & admin
17,586
Communications Fundraising
£
£
Management & admin
27,990
5,034
Knowledge
Centre
Conversations
£
£
Management & admin
36,736
23,501 |
Governance
costs
£
1,821
-
-
1,456
-
-
-
1,456
1,456
6,189
Diagnosis
& testing
£
11,784
Cure
Consortium
£
10,926
2022
Total
activities
£
157,745 |
Totals
£
20,242
11,784
1,785
29,446
7,017
10,926
22,403
38,192
24,957
166,752
Scientific
meetings
£
1,785
Candid
£
22,403
2021
Total
activities
£
132,913 |
|
|
|
continued...
Page 9
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST AUGUST 2022
4. SUPPORT COSTS - continued Finance
5.
SUPPORT COSTS - continued
Finance |
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
|
|
Other |
|
|
|
|
|
|
|
resources |
|
|
Total |
|
Total |
|
|
expended |
Fundraising |
|
activities |
|
activities |
|
|
£ |
£ |
|
£ |
|
£ |
|
Bank charges |
268 |
17 |
|
285 |
|
395 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
|
|
Other |
|
|
|
|
|
|
|
resources |
|
|
Total |
|
Total |
|
|
expended |
Fundraising |
|
activities |
|
activities |
|
|
£ |
£ |
|
£ |
|
£ |
|
Sundry office costs |
567 |
1,966 |
|
2,533 |
|
2,631 |
|
Governance costs |
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
resources |
|
|
|
Knowledge |
|
|
|
expended |
Communications |
|
|
Centre |
|
|
|
£ |
|
£ |
|
£ |
|
Accountancy - Independent |
|
|
|
|
|
|
|
examination fee |
|
- |
|
1,456 |
|
1,456 |
|
Legal and Professional fees |
|
1,821 |
|
|
- |
|
- |
|
|
1,821 |
|
1,456 |
|
1,456 |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
|
Total |
|
Total |
|
|
|
Conversations |
|
activities |
|
activities |
|
|
|
£ |
|
£ |
|
£ |
|
Accountancy - Independent |
|
|
|
|
|
|
|
examination fee |
|
1,456 |
|
4,368 |
|
4,242 |
|
Legal and Professional fees |
|
- |
|
1,821 |
|
|
- |
|
|
1,456 |
|
6,189 |
|
4,242 |
|
NET INCOME/(EXPENDITURE) |
|
|
|
|
|
|
|
Net income/(expenditure) is stated after charging/(crediting): |
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
|
£ |
|
£ |
|
Accountancy - Independent examination fee |
|
|
|
4,368 |
|
4,242 |
|
continued...
Page 10
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2022
6. TRUSTEES' REMUNERATION AND BENEFITS
Therewerenotrustees'remunerationorotherbenefitsfortheyearended31stAugust2022 nor
for the year ended 31st August 2021.
Trustees' expenses
Therewerenotrustees'expensespaidfortheyearended31stAugust2022norforthe year
ended 31st August 2021.
7. STAFF COSTS
The average monthly number of employees during the year was as follows:
|
2022 |
2021 |
Charitable activities |
4 |
4 |
Thenumberofemployeeswhoseemployeebenefits(excludingemployerpensioncosts) exceeded
£60,000 was:
8.
£80,001 - £90,000
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
8,459
Other income
(5,904)
Total
2,555
EXPENDITURE ON
Charitable activities
Scientific meetings
696
ICMLF Forum
3,402
Communications
1,414
Fundraising
5,818
Cure Consortium
-
Candid
39
Knowledge Centre
21,529
Conversations
27,098
Other
13,891
Total
73,887
NET INCOME/(EXPENDITURE)
(71,332)
RECONCILIATION OF FUNDS
Total funds brought forward
228,033 |
|
2022
1
Restricted
funds
£
66,648
-
66,648
-
-
27,617
3,095
5,147
35,074
-
1,840
-
72,773
(6,125)
154,771 |
2021
1
Total
funds
£
75,107
(5,904)
69,203
696
3,402
29,031
8,913
5,147
35,113
21,529
28,938
13,891
146,660
(77,457)
382,804 |
|
|
|
|
continued...
Page 11
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2022
8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
funds
£
TOTAL FUNDS CARRIED FORWARD
156,701 |
Restricted
funds
£
148,646 |
Total
funds
£ |
|
|
305,347 |
9. VOLUNTEERS
Thecharityheavilyreliesuponthemanymedicalprofessionalswhodonatetheirtimetohelp run
thevariouscharitableactivitiesundertaken.Itisnotpossibletoaccuratelycalculatethevalue of
theservicescontributedbythesevolunteersandthereforethenumbersdonotreflecteither the
income or expenditure, however it is thought to be in the region of £230,000.
10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
|
2022 |
2021 |
|
£ |
£ |
Other debtors |
102,793 |
86,793 |
Includedwithinotherdebtorsisabalanceof£88,015inrespectoffundsheldbyPaypal.As a
resultofachangeofpersonnel,theaccountaccessisbeingtransferredbyPaypal,anduntil this
process has been completed the charity cannot transfer or use these funds.
11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Accrued expenses
MOVEMENT IN FUNDS
Unrestricted funds
General fund
Restricted funds
Novartis Pharmaceuticals Corporation
Pfizer
Novartis Patient
Novartis Pharma AG
TOTAL FUNDS |
At 1/9/21
£
156,702
123,410
24,863
372
-
148,645
305,347 |
2022
£
4,368
Net
movement
in funds
£
55,307
(11,784)
(24,863)
(372)
4,905
(32,114)
23,193 |
2021
£
4,272
At
31/8/22
£
212,009
111,626
-
-
4,905 |
2021
£
4,272 |
|
|
|
116,531 |
|
|
|
|
328,540 |
|
12. MOVEMENT IN FUNDS
continued...
Page 12
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2022
12. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
Restricted funds
Novartis Pharmaceuticals Corporation
Pfizer
Novartis Patient
Novartis Pharma AG
TOTAL FUNDS |
Incoming
resources
£
143,188
-
-
-
66,043
66,043
209,231 |
Resources
expended
£
(87,881)
(11,784)
(24,863)
(372)
(61,138)
(98,157)
(186,038) |
Movement
in funds
£
55,307
(11,784)
(24,863)
(372)
4,905
(32,114)
23,193 |
|
|
|
|
Comparatives for movement in funds
Unrestricted funds
General fund
Cepheid
Restricted funds
Novartis Pharmaceuticals Corporation
Pfizer
Novartis Killi Climb
Novartis Patient
TOTAL FUNDS |
At 1/9/20
£
224,118
3,915
228,033
123,410
23,118
8,243
-
154,771
382,804 |
Net
movement
in funds
£
(67,416)
(3,915)
(71,331)
-
1,745
(8,243)
372
(6,126)
(77,457) |
At
31/8/21
£
156,702
- |
|
|
|
156,702
123,410
24,863
-
372 |
|
|
|
148,645 |
|
|
|
305,347 |
continued...
Page 13
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST AUGUST 2022
12. MOVEMENT IN FUNDS - continued
Comparative net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
Cepheid
Restricted funds
Takeda Oncology
Pfizer
Novartis Killi Climb
Novartis Patient
TOTAL FUNDS |
Incoming
resources
£
2,555
-
2,555
29,457
36,819
-
372
66,648
69,203 |
Resources
expended
£
(69,971)
(3,915)
(73,886)
(29,457)
(35,074)
(8,243)
-
(72,774)
(146,660) |
Movement
in funds
£
(67,416)
(3,915)
(71,331)
-
1,745
(8,243)
372
(6,126)
(77,457) |
|
|
|
|
A current year 12 months and prior year 12 months combined position is as follows:
Unrestricted funds
General fund
Cepheid
Restricted funds
Novartis Pharmaceuticals Corporation
Pfizer
Novartis Killi Climb
Novartis Pharma AG
TOTAL FUNDS |
At 1/9/20
£
224,118
3,915
228,033
123,410
23,118
8,243
-
154,771
382,804 |
Net
movement
in funds
£
(12,109)
(3,915)
(16,024)
(11,784)
(23,118)
(8,243)
4,905
(38,240)
(54,264) |
At
31/8/22
£
212,009
- |
|
|
|
212,009
111,626
-
-
4,905 |
|
|
|
116,531 |
|
|
|
328,540 |
continued...
Page 14
THE INTERNATIONAL CML FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2022
12. MOVEMENT IN FUNDS - continued
Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
Unrestricted funds
General fund
Cepheid
Restricted funds
Novartis Pharmaceuticals Corporation
Takeda Oncology
Pfizer
Novartis Killi Climb
Novartis Patient
Novartis Pharma AG
TOTAL FUNDS |
Incoming
resources
£
145,743
-
145,743
-
29,457
36,819
-
372
66,043
132,691
278,434 |
Resources
expended
£
(157,852)
(3,915)
(161,767)
(11,784)
(29,457)
(59,937)
(8,243)
(372)
(61,138)
(170,931)
(332,698) |
Movement
in funds
£
(12,109)
(3,915)
(16,024)
(11,784)
-
(23,118)
(8,243)
-
4,905
(38,240)
(54,264) |
|
|
|
|
13. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31st August 2022.
Page 15